source
- FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell LymphomaThe FDA granted accelerated approval to sonrotoclax for relapsed/refractory mantle cell lymphoma after at least 2 lines of systemic therapy.onclive · 2mo ago↗ source
- Dr Dinardo on the FDA Approval of Decitabine/Cedazuridine Plus Venetoclax in AMLCourtney D. DiNardo, MD, MSCE, discusses the FDA approval of decitabine/cedazuridine plus venetoclax in acute myeloid leukemia.onclive · 2mo ago↗ source
- Opinion: Hospitals are silencing doctors online, and it’s fueling the health misinformation crisisHospitals and health systems need to loosen the reins and let physicians combat social media misinformation, writes Adam Goodcoff.STAT · 2mo ago